Come up with a name for your new list and we'll add to it:
Kereos raised a round of funding on June 08, 2001. Investors include
RiverVest Venture Partners.
Kereos develops targeted molecular imaging agents and therapeutics designed to detect and treat cancer and cardiovascular disease earlier and more specifically than currently possible. The specificity…